US2010222362A1PendingUtilityA1
N-oxides of n-phenyl-2-pyramidine-amine derivatives
Est. expiryJan 23, 2022(expired)· nominal 20-yr term from priority
A61P 31/04A61P 9/00A61P 35/00A61P 9/10A61P 37/06A61P 7/00A61P 7/02A61P 35/02A61P 43/00A61P 17/06C07D 401/04C07D 401/14A61P 11/00A61P 11/06
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to N-phenyl-2-pyrimidine-amine derivatives derivatives in which at least one nitrogen atom carries an oxygen atom to form the corresponding N-oxides, to processes for the preparation thereof, to pharmaceutical compositions comprising those compounds, and to the use thereof in the preparation of pharmaceutical compositions for the therapeutic treatment of warm-blooded animals, including humans.
Claims
exact text as granted — not AI-modified1 . A compound which is 4-[(methyl-1-piperazinyl)-methyl]-N-[4-methyl-3-[[4-(1-oxido-3-pyridinyl)-2-pyrinidinyl]-amino]-phenyl]-benzamide, or a pharmaceutically acceptable salt thereof.
2 . A pharmaceutical composition comprising a compound according to claim 1 together with a pharmaceutically acceptable carrier.
3 . A method of treating a warm-blooded animal suffering from a proliferative disorder, which comprises administering to the warm-blooded animal a dose effective against the disorder of a compound according to claim 1 .Join the waitlist — get patent alerts
Track US2010222362A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.